Revenue - Significant Customers (Details) - Revenue - Customer concentration risk |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| United | ||||
| Concentration Risk [Line Items] | ||||
| Revenue percent | 43.40% | 22.20% | 39.20% | 18.30% |
| Humana | ||||
| Concentration Risk [Line Items] | ||||
| Revenue percent | 22.70% | 25.30% | 27.20% | 20.30% |
| Elevance Health | ||||
| Concentration Risk [Line Items] | ||||
| Revenue percent | 14.20% | 15.60% | 12.30% | 20.10% |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|